We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.21B
AUM Growth
+$1.17B
Cap. Flow
+$1.31B
Cap. Flow %
15.93%
Top 10 Hldgs %
19.59%
Holding
1,801
New
278
Increased
701
Reduced
627
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Financials 9.29%
3 Industrials 9.2%
4 Healthcare 6.57%
5 Communication Services 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BME icon
1451
BlackRock Health Sciences Trust
BME
$547M
$261K ﹤0.01%
6,774
-14
-0.2% -$577
NXJ
1452
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$260K ﹤0.01%
21,116
+1,205
+6% +$15K
AG icon
1453
First Majestic Silver
AG
$8.12B
$258K ﹤0.01%
12,034
-797
-6% -$18.4K
JRS icon
1454
Nuveen Real Estate Income Fund
JRS
$250M
$258K ﹤0.01%
34,614
-1,872
-5% -$14.6K
CYTK icon
1455
Cytokinetics
CYTK
$11.1B
$258K ﹤0.01%
3,908
-14
-0.4% -$890
MDGL icon
1456
Madrigal Pharmaceuticals
MDGL
$12.5B
$258K ﹤0.01%
492
+100
+26% +$47.8K
CDNS icon
1457
Cadence Design Systems
CDNS
$91.1B
$257K ﹤0.01%
+924
New +$276K
PZZA icon
1458
Papa John's
PZZA
$999M
$257K ﹤0.01%
+7,920
New +$275K
IBDR icon
1459
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.46B
$255K ﹤0.01%
10,516
-5,171
-33% -$125K
GCC icon
1460
WisdomTree Enhanced Commodity Strategy Fund
GCC
$274M
$254K ﹤0.01%
+10,629
New +$244K
JBS
1461
JBS N.V.
JBS
$39.9B
$254K ﹤0.01%
14,165
+30
+0.2% +$467
TSN icon
1462
Tyson Foods
TSN
$20B
$254K ﹤0.01%
3,966
-17,640
-82% -$1.1M
ZFEB
1463
Innovator Equity Defined Protection ETF - 1 Yr February
ZFEB
$155M
$254K ﹤0.01%
+10,000
New +$255K
CFR icon
1464
Cullen/Frost Bankers
CFR
$10.1B
$254K ﹤0.01%
1,850
-1,169
-39% -$161K
EVR icon
1465
Evercore
EVR
$13B
$253K ﹤0.01%
848
APO.PRA icon
1466
Apollo Global Management Series A
APO.PRA
$1.74B
$253K ﹤0.01%
4,327
-25
-0.6% -$1.62K
CRDO icon
1467
Credo Technology Group
CRDO
$44.1B
$253K ﹤0.01%
+2,691
New +$328K
TENB icon
1468
Tenable Holdings
TENB
$3.49B
$252K ﹤0.01%
14,900
-900
-6% -$18.9K
SPDW icon
1469
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.7B
$251K ﹤0.01%
+5,501
New +$258K
ISHG icon
1470
iShares 1-3 Year International Treasury Bond ETF
ISHG
$853M
$250K ﹤0.01%
3,374
+7
+0.2% +$529
PFIX icon
1471
Simplify Interest Rate Hedge ETF
PFIX
$171M
$250K ﹤0.01%
+5,413
New +$247K
PR
1472
Permian Resources
PR
$17.9B
$250K ﹤0.01%
+11,735
New +$203K
KTF
1473
DWS Municipal Income Trust
KTF
$347M
$250K ﹤0.01%
27,468
+6,026
+28% +$54.9K
PBF icon
1474
PBF Energy
PBF
$7.33B
$249K ﹤0.01%
+5,224
New +$196K
TAP icon
1475
Molson Coors Class B
TAP
$7.51B
$248K ﹤0.01%
5,759
+189
+3% +$8.98K

Similar funds

Oppenheimer & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Oppenheimer & Co held 1,801 positions worth $8.21B, up 17% from $7.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co deployed $1.31B of net new capital in Q1 2026, opening 278 new positions and adding to 701 existing holdings. Its largest new stake was Apple: 1,107,179 shares worth $281M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $11.2M trimmed.

  • Oppenheimer & Co's largest Q1 2026 buy was Apple: 1,107,179 shares worth $281M.
  • Oppenheimer & Co added most to Microsoft in Q1 2026, an estimated $24M increase.
  • Oppenheimer & Co's biggest Q1 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $11.2M.
  • Oppenheimer & Co fully exited Telefonica in Q1 2026, selling an estimated $6.36M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $8.21B portfolio in Q1 2026.
  • Oppenheimer & Co opened 278 new positions and closed 118 in Q1 2026.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $8.21B.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.